Dataset from An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009156
下载链接
链接失效反馈官方服务：
资源简介：
GW433908 (fosamprenavir; FPV)is a pro-drug of amprenavir (APV) which is more water soluble
and can be formulated into a tablet with a reduced pill burden (four 700mg tablets of FPV
versus sixteen 150mg capsules daily for APV. This study is designed to provide additional
information on long term safety and tolerability of FPV containing regimens for those
subjects who received FPV in previous GlaxoSmithKline studies.
创建时间：
2024-11-27
